EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems, a leader in drug safety and ADMET (absorption, distribution, metabolism, excretion and toxicity) testing, today announced the introduction of a more complete series of drug metabolism assays designed to support the pharmaceutical R&D process, from early-stage discovery through late-stage clinical development. The tests are intended to provide researchers with a more comprehensive picture of the role that metabolites, which are generally associated with the body’s detoxification process, play in drug safety. If metabolites are not produced by and eliminated from the body in a timely fashion, a drug’s active ingredients can accumulate and increase the potential for adverse reactions.
